CO-RAD

160 views 35 slides May 09, 2021
Slide 1
Slide 1 of 35
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35

About This Presentation

This ppt is all about the test by which we can detect covid virus , RT-PCR, Rapid antigen test,CT Chest all 3 test are properly mentioned .
The importance of Ct in covid and how to check the level of severity by CORAD .
This also involves comparision between CT and RT-PCCR in case of Covid.


Slide Content

CO-RAD DEEPAK NEGI MRIT TMU

CONTENT COVID-19 DETECTION OF COVID-19 RAPID ANTIBODY TEST RT-PCR TEST CT CHEST SCAN CT PROTOCOLS FOR COVID PATIENT CO-RAD CONCLUSION

COVID-19 COVID-19 (coronavirus disease 2019) is an infectious disease caused by SARS-CoV-2 ( severe acute respiratory syndrome coronavirus 2 ), a strain of coronavirus. The first cases were seen in Wuhan ,CHINA in December 2019. Spreads primarily through droplets of saliva or discharge from the nose .

DETECTION OF COVID-19 RT-PCR ( reverse transcription-polymerase chain reaction) RAPID ANTIBODY TEST CHEST CT SCAN

RT-PCR A PCR is performed to detect genetic material from a specific organism such as a virus . 3 key steps to COVID-19 test SAMPLE COLLECTION EXTRACTION PCR (THERMAL CYCLER)

RAPID ANTIBODY TEST

CT CHEST SCAN CT scanning is a fast, painless, noninvasive and accurate radiological examination. Computed tomography (CT) of the chest  is a cross-sectional evaluation of the heart, airways, lungs, mediastinum, and associated bones and soft tissues.

Continue HRCT (High-resolution computed tomography) is the most preferred method for COVID-19 cases. NCCT (non-enhanced computed tomography ) for severe patients . CECT (contrast enhanced computed tomography) in case if there is complain of pulmonary hypertension. EVALUATION CRITERIA- (1) Site of lung involvement (2) Universally agreed CT findings with COVID-19 including ground-glass opacities (GGO) with or without consolidative changes in addition to special signs such as “Atoll sign” and “Crazy paving pattern” [ 3 ] Manifestations of bronchial or pleural involvement.

CT PROTOCOLS FOR COVID-19 Low-radiation-dose CT images by using lower kilovoltage settings Helical mode volumetric HRCT with 100-120 kVp and 80-200 Ma For CT examinations at risk for motion artifact, lowering the rotation time of the tube detector system with high pitch and wide collimation values may be considered . 1 mm slice thickness, 1 mm detector collimation, 0.6-0.9 s tube rotation. CT images should be acquired during a single inspiratory breath hold. Expiratory phase CT increases radiation dose . Multi-planner reconstruction (MPR) for image analysis. Post-processing maximum intensity projection (MIP) and minimum intensity projection (Min-IP) reconstructions used. AI learning–based reconstructions for noise reduction, and spectral shaping of the x-ray beam to reduce the low-energy component of the x-ray spectrum.

CO-RAD COVID-19 Reporting and Data System In early March 2020, the Dutch Radiological Society initiated a COVID-19 network to facilitate development and nationwide dissemination of COVID-19–related information and tools. A COVID-19 standardized reporting working group was formed.

CO-RADS Category 0 If scans are incomplete or of insufficient quality, for example because of severe artifacts due to coughing or breathing.

CO-RADS Category 1 CO-RADS category 1 implies a very low level of suspicion for pulmonary involvement by COVID-19 based on normal CT results. It refers to normal findings. Mild or severe emphysema, perifissural nodules, lung tumors, and fibrosis are classified as CO-RADS category 1 findings.

CO-RADS 1. Normal chest CT.

CO-RADS Category 2 CO-RADS category 2 implies a low level of suspicion for pulmonary involvement by COVID-19 based on CT findings. Involves lung infectious origin that are considered not compatible with COVID-19 . Examples are bronchitis, infectious bronchiolitis, bronchopneumonia , lobar pneumonia, and pulmonary abscess. lobar or segmental consolidation, and lung cavitation.

CO-RADS 2. Non COVID-19 infection

CO-RADS 2

CO-RADS 2. Bacterial pneumonia with endobronchial spread (tree-in-bud)

CO-RADS Category 3 CO-RADS category 3 implies equivocal findings for pulmonary involvement of COVID-19 based on CT features. Findings include perihilar ground-glass opacity, homogenous extensive ground-glass opacity or ground-glass opacity together with smooth interlobular septal thickening with or without pleural effusion in the absence of other typical CT findings.

CO-RADS 3

CO-RADS 3

CO-RADS Category 4 CO-RADS category 4 implies a high level of suspicion for pulmonary involvement by COVID-19 based on CT findings. S how some overlap with other (viral) pneumonias

CO-RAD 4

CO-RADS Category 5 CO-RADS category 5 implies a very high level of suspicion for pulmonary involvement by COVID-19 based on typical CT findings. F eatures are ground-glass opacities with or without consolidations in lung regions close to visceral pleural surfaces, including the fissures, and a multifocal bilateral distribution.

CO-RAD 5

CO-RAD 5

CO-RADS Category 6 I ntroduced to indicate proven COVID-19, as signified by positive RT-PCR test results for virus-specific nucleic acid.

CO-RAD 6

FINDINGS IN CHEST CT

S tages of COVID-19 at chest CT (A) E arly stage (0–5 days after symptom onset), which is characterized by either normal findings or mainly ground-glass opacities. (B) P rogressive stage (5–8 days after symptom onset), which is characterized by increased ground-glass opacities and crazy-paving appearance . (C) P eak stage ( 9–13 days after symptom onset), which is characterized by progressive consolidation . (D) L ate stage ( ≥14 days after symptom onset), which is characterized by a gradual decrease of consolidation and ground-glass opacities, while signs of fibrosis .

PROGRESS OF INFECTION

CONCLUSION Performing CT in patients with suspected or proven COVID-19 requires comprehensive precautionary safety measures. Low-radiation-dose chest CT is recommended unless CT pulmonary angiography is required to evaluate for Pulmonary embolism. C hest CT shows (ground-glass opacities, vascular enlargement, bilateral abnormalities, lower lobe involvement, and posterior predilection), this may help in diagnostic decision making. C hest CT should not be used as an independent diagnostic tool to exclude or confirm COVID-19. RT-PCR test results are the standard for diagnosis and key component in clinical decision making. Best to know the severity and lung area affected by the virus.

REFERENCE https:// pubs.rsna.org/doi/full/10.1148/radiol.20202040130 https://www.rsna.org/-/ media/Files/RSNA/Covid-19/RSNA-COVID19ChestCT-ReportExample

THANKYOU